CBRE, Colliers International and Jones Lang LaSalle Americas sign Xceligent

August 26, 2013 - Front Section
Xceligent, Inc., a leading provider of proactively researched commercial real estate information and marketing solutions, announced that CBRE Group, Inc., Colliers International, and Jones Lang LaSalle Americas, Inc. have signed multi-year agreements for Xceligent researched products. The agreements provide for access to the Xceligent platform in all existing and future US markets, including the 100+ markets to be launched as part of Xceligent's national rollout of its comprehensive research solution.
Through the multi-year agreements, CBRE, Colliers International, and Jones Lang LaSalle professionals will be able to provide their clients comprehensive and certified market information to make well-informed business decisions, as well as provide exposure of their clients' available properties to millions of potential buyers and lessors. Over its 14-year history, Xceligent has a track record of partnering with the industry, both nationally and at the local market level.
"The support of the global firms is an integral piece of our overall plans to successfully bring our services to the entire US market. We are thrilled to have three of the top US brokerage firms support our national expansion plans, which will accelerate market penetration," said Doug Curry, Xceligent founder and CEO. "These relationships will enrich the competitive landscape for commercial real estate information and lend tremendous credibility to our mission and objectives."
In 2012, Xceligent received a strategic investment from dmg information (dmgi), the US information division of DMGT that manages and develops a portfolio of high-growth, innovative companies that provide business-to-business information to the commercial real estate, education, energy and commodity and structured finance markets.
Suresh Kavan, CEO of dmg information said, "It is exciting to see such leading firms sign up for Xceligent's services. It is a terrific vote of confidence in Xceligent's continued market expansion and product innovation."
Thanks for Reading!
You've read 2 of your 3 guest articles
Register and get instant unlimited access to all of our articles online.

Sign up is quick, easy, & FREE.
Subscription Options
Already have an account? Login here
Tags:

Comments

Add Comment